Zhu, Andrew X <br/><br/>
Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies.  [electronic resource] 

 -  Cancer journal (Sudbury, Mass.)   
 - 263-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1528-9117 
<br/><br/><label>Standard No.: </label>10.1097/PPO.0b013e3181af5e35  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor<br/>Carcinoma, Hepatocellular--drug therapy<br/>Humans<br/>Indoles--therapeutic use<br/>Liver Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--therapeutic use<br/>Statistics as Topic<br/>Sunitinib<br/>Vascular Endothelial Growth Factor A--drug effects